Y. MORIMOTO

430 total citations
20 papers, 365 citations indexed

About

Y. MORIMOTO is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Y. MORIMOTO has authored 20 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Biochemistry. Recurrent topics in Y. MORIMOTO's work include Eicosanoids and Hypertension Pharmacology (3 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Y. MORIMOTO is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (3 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (2 papers). Y. MORIMOTO collaborates with scholars based in Japan, United States and Egypt. Y. MORIMOTO's co-authors include Takayuki Sukamoto, Samir A.M. Abdelgaleil, Matsumi Doe, Munehiro Nakatani, Shigetaka Koda, Satoshi Kitamura, Toshihiko Fukuda, Tsutomu Yasuda, Takao Asano and Kintomo Takakura and has published in prestigious journals such as Stroke, International Journal of Pharmaceutics and Phytochemistry.

In The Last Decade

Y. MORIMOTO

15 papers receiving 339 citations

Peers

Y. MORIMOTO
Y. MORIMOTO
Citations per year, relative to Y. MORIMOTO Y. MORIMOTO (= 1×) peers M.B. Gupta

Countries citing papers authored by Y. MORIMOTO

Since Specialization
Citations

This map shows the geographic impact of Y. MORIMOTO's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. MORIMOTO with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. MORIMOTO more than expected).

Fields of papers citing papers by Y. MORIMOTO

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. MORIMOTO. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. MORIMOTO. The network helps show where Y. MORIMOTO may publish in the future.

Co-authorship network of co-authors of Y. MORIMOTO

This figure shows the co-authorship network connecting the top 25 collaborators of Y. MORIMOTO. A scholar is included among the top collaborators of Y. MORIMOTO based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. MORIMOTO. Y. MORIMOTO is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yasunaga, Takuo, et al.. (2026). Establishing functional giant Dictyostelium cells reveals front–rear polarity in intracellular signaling. Communications Biology. 9(1). 71–71.
2.
MORIMOTO, Y., et al.. (2025). Initiatives toward Realization of a Circular Economy by the Panasonic Group. Material Cycles and Waste Management Research. 36(4). 296–301.
3.
Abdelgaleil, Samir A.M., Matsumi Doe, Y. MORIMOTO, & Munehiro Nakatani. (2006). Rings B,D-seco limonoids from the leaves of Swietenia mahogani. Phytochemistry. 67(5). 452–458. 49 indexed citations
4.
Haga, Keiichiro, et al.. (1995). Effect of Y-25130, a selective 5-hydroxytryptamine3 receptor antagonist, on gastric emptying in mice.. PubMed. 328(3). 344–55. 12 indexed citations
5.
MORIMOTO, Y., et al.. (1994). Effects of KB-5492, a New Anti-Ulcer Agent with a Selective Affinity for the Sigma-Receptor, on Aspirin-Induced Disruption of the Rat Gastric Mucosal Barrier. The Japanese Journal of Pharmacology. 64(1). 49–56. 9 indexed citations
8.
Kitamura, Satoshi, et al.. (1990). Dehydration effect on the stability of cefixime trihydrate. International Journal of Pharmaceutics. 59(3). 217–224. 28 indexed citations
10.
Saito, Taichi, et al.. (1988). General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 1st communication: effects on the central nervous system.. PubMed. 38(1). 66–9. 4 indexed citations
11.
Saito, Taichi, Takeo Fukuda, Shunji Tajima, et al.. (1988). General pharmacology of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole difumarate. 2nd communication: Effects on the circulation and the other systems.. PubMed. 38(2). 267–72. 2 indexed citations
12.
Hirai, Osamu, et al.. (1987). Antitumour Activity of Purified Arabinogalactan-peptidoglycan Complex of the Cell Wall Skeleton of Rhodococcus lentifragmentus. Microbiology. 133(2). 369–373. 7 indexed citations
13.
Koda, Shigetaka, et al.. (1985). Novel Glycosidic Linkage between Arabinogalactan and Peptidoglycan in the Cell Wall Skeleton of Nocardia rubra AN-115. Microbiology. 131(6). 1323–1329. 9 indexed citations
14.
MORIMOTO, Y., et al.. (1984). [Effect of nizofenone (Y-9179) on experimental cerebral ischemia in Mongolian gerbils].. PubMed. 83(6). 507–11. 1 indexed citations
15.
16.
Morita, T., Toshihiko Fukuda, Takayuki Sukamoto, et al.. (1982). General pharmacology of KB-944, a new calcium antagonist.. PubMed. 32(9). 1060–8.
18.
Nakajima, Ayako, et al.. (1978). Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), a new anti-anxiety drug.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 28(7). 1158–64. 20 indexed citations
19.
Shinomura, Yasuhisa, et al.. (1976). [Pseudoaldosteronism induced by administration of a massive dose of glycyrrhizin].. PubMed. 34(2). 390–4. 1 indexed citations
20.
MORIMOTO, Y., et al.. (1967). Proton magnetic resonance spectra of malonato-containing cobalt (III) complexes. Inorganica Chimica Acta. 1. 413–414. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026